CONTIPRO PHARMA AS - Czech Republic 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2014-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2015 0 8.832.062 600.625 1
2014 0 3.409.540 303.960 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABIEL SOCIETA A RESPONSABILITA LIMITATA1
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA1
BOSTON SCIENTIFIC LIMITED1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
DUBLIN CITY UNIVERSITY1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EXPLORA1
FUNDACION TEKNIKER1
HISTOCELL SL1
INNOCORE TECHNOLOGIES BV1
INNOVA1
QSERVE CONSULTANCY B V1
ROYAL COLLEGE OF SURGEONS IN IRELAND1
SERVICIO DE SALUD DE CASTILLA LA MANCHA1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF SHEFFIELD1
THE UNIVERSITY OF WESTMINSTER LBG1
UNIVERSITEIT UTRECHT1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN1
VORNIA LIMITED1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2015-06-01Diabetes Reversing Implants with enhanced Viability and long-term Efficacy DRIVEparticipant8.832.06214
2014-01-01Novel combination of biopolymers and manufacturing technologies for production of a peripheral nerve implant containing an internal aligned channels array NEURIMPparticipant3.409.5408